COVID‐19 infection in CVID patients: What we know so far
N Weifenbach, A Jung, S Lötters - Immunity, Inflammation and …, 2021 - Wiley Online Library
Introduction In patients with common variable immunodeficiency (CVID), immunological
response is compromised. Knowledge about COVID‐19 in CVID patients is sparse. We …
response is compromised. Knowledge about COVID‐19 in CVID patients is sparse. We …
Impact of SARS-CoV-2 pandemic on patients with primary immunodeficiency
S Delavari, H Abolhassani, F Abolnezhadian… - Journal of clinical …, 2021 - Springer
Although it is estimated that COVID-19 life-threatening conditions may be diagnosed in less
than 1: 1000 infected individuals below the age of 50, but the real impact of this pandemic …
than 1: 1000 infected individuals below the age of 50, but the real impact of this pandemic …
[HTML][HTML] Primary immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor?
The novel coronavirus disease 19 (COVID-19) is an acute infectious respiratory disorder that
emerged from Wuhan, China in the late 2019. 1, 2 Due to its rapid distribution, the disease …
emerged from Wuhan, China in the late 2019. 1, 2 Due to its rapid distribution, the disease …
SARS-CoV-2 T cell response in severe and fatal COVID-19 in primary antibody deficiency patients without specific humoral immunity
S Steiner, T Schwarz, VM Corman, L Gebert… - Frontiers in …, 2022 - frontiersin.org
Morbidity and mortality of COVID-19 is increased in patients with inborn errors of immunity
(IEI). Age and comorbidities and also impaired type I interferon immunity were identified as …
(IEI). Age and comorbidities and also impaired type I interferon immunity were identified as …
SARS-CoV-2-associated T-cell responses in the presence of humoral immunodeficiency
S Gupta, H Su, T Narsai, S Agrawal - International archives of allergy …, 2021 - karger.com
We report perhaps the most comprehensive study of subsets of CD4+ and CD8+ and
subsets of B cells in a mild symptomatic SARS-CoV-2+ immunocompetent patient and a …
subsets of B cells in a mild symptomatic SARS-CoV-2+ immunocompetent patient and a …
Minor clinical impact of COVID-19 pandemic on patients with primary immunodeficiency in Israel
N Marcus, S Frizinsky, D Hagin, A Ovadia… - Frontiers in …, 2021 - frontiersin.org
In the last few months the world has witnessed a global pandemic due to severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection causing coronavirus disease …
respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection causing coronavirus disease …
Immunologic interplay between HIV/AIDS and COVID-19: adding fuel to the flames?
M Augello, V Bono, R Rovito, C Tincati… - Current HIV/AIDS …, 2023 - Springer
Abstract Purpose of Review HIV/AIDS and COVID-19 have been the major pandemics
overwhelming our times. Given the enduring immune disfunction featuring people living with …
overwhelming our times. Given the enduring immune disfunction featuring people living with …
Why do some people develop serious COVID-19 disease after infection, while others only exhibit mild symptoms?
M Ballow, CL Haga - The Journal of Allergy and Clinical Immunology: In …, 2021 - Elsevier
The year 2020 was a landmark year of a once-in-a-century pandemic of a novel coronavirus,
SARS-CoV-2 virus, that led to a rapidly spreading coronavirus disease (COVID-19). The …
SARS-CoV-2 virus, that led to a rapidly spreading coronavirus disease (COVID-19). The …
Robust antibody and T cell responses to SARS-CoV-2 in patients with antibody deficiency
H Kinoshita, J Durkee-Shock… - Journal of Clinical …, 2021 - Springer
Immunocompromised patients, including those with inborn errors of immunity (IEI), may be at
increased risk for severe or prolonged infections with SARS-CoV-2 (Zhu et al. N Engl J Med …
increased risk for severe or prolonged infections with SARS-CoV-2 (Zhu et al. N Engl J Med …
Coronavirus disease-2019 in the immunocompromised host
CD Bertini, F Khawaja… - Clinics in Chest …, 2023 - chestmed.theclinics.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory virus that
originated in Wuhan, China in 2019. Since that time, SARS-CoV-2 has been responsible for …
originated in Wuhan, China in 2019. Since that time, SARS-CoV-2 has been responsible for …